New Olympic-Style Event to Allow Performance-Enhancing Drugs
A new and controversial sporting event, which permits the use of performance-enhancing drugs, is set to launch in Las Vegas next May, according to organizers.
Scheduled from May 21-24, 2026, the inaugural event will take place at Resorts World on the Las Vegas Strip. For four days, athletes will race, lift weights, and swim, all while having access to substances typically banned in elite athletics.
This event, which some have termed a revolution in sports and science, aims to celebrate what the organizers call “superhumans.” While promoters see it as a daring shift from traditional sports, critics are raising concerns about safety, fairness, and the integrity of athletics.
The promotional materials claim, “We are creating a new category of human excellence. A world where performance-enhancing drugs are used safely, openly, and under medical supervision.”
The concept is quite radical; rather than punishing athletes for using banned substances, it welcomes and studies their use in medically supervised settings. In this model, athletes can choose to compete naturally or participate in trials using FDA-approved “search drugs.”
Aron Douza, the founder of the event and an entrepreneur based in London, argues that existing anti-doping policies are outdated and hypocritical. “The enhanced game is updating the Olympic models of the 21st century,” he stated, emphasizing the need for sports to adapt alongside advancements in technology and medicine.
While extensive medical checks and oversight from an independent ethics committee are promised, athletes won’t undergo traditional anti-doping tests. Instead, they’ll have to disclose their substance use—something some critics interpret as a “don’t ask, don’t tell” approach to doping.
The event will include sprints, swimming, and weightlifting, with promising prize money—up to $500,000 per event, including a $1 million bonus for breaking records in the 100m sprint or 50m freestyle.
This comes after Greek swimmer Christian Gkolomev recently recorded a 20.89 second time in the 50m freestyle—a record that’s stood since 2009. Interestingly, his swim was filmed for promotional content but involved a full-body suit that wasn’t approved by swimming’s governing body, raising ethical questions.
Many people are frankly uneasy about this entire idea. The global anti-doping agency pointed out the potential risks, saying, “Performance-enhancing drugs have come with severe consequences for many athletes, including fatalities.” They expressed worries about athletic health regarding this event’s encouragement of substance use.
Travis Tygart, the CEO of a U.S. anti-doping agency, was less than impressed, calling it a “dangerous clown show.” Supporters, however, argue that the event has stirred excitement and controversy. It has garnered investment from notable entities, including Donald Trump Jr.’s company, 1789 Capital.
Douza described this partnership with prominent figures in the Trump administration as a logical fit for the event. “Their involvement is more significant than mere investment,” he said.
Notably, Peter Thiel, known for his participation in controversial biotech endeavors, is also listed as a major investor and advisor.
Critics have scrutinized the event further, seeing it as not just a departure from the established Olympic model, but as a provocative challenge to anti-doping agencies and traditional sports governance.
Organizers clarify that they’re not trying to replace existing Olympic records; rather, they view these enhanced games as a parallel to traditional sports, aiming to push the limits of human capability and spark broader discussions on athleticism.
It’s a bold vision, but it poses a significant gamble.
Recruitment includes athletes from around the world, especially those who feel sidelined by anti-doping regulations. Australia’s recent efforts have been met with scrutiny, yet former world swimming champion James Magnussen has shown interest.
While organizers insist they will not tolerate illegal drug use, enforcement seems to focus more on partnerships than strict oversight. “Elite sports always have risks,” one FAQ states. “We believe that denying these risks only adds to the danger.”
How the public will react remains uncertain. Organizers have open discussions with potential sponsors but haven’t secured major broadcasting partnerships yet. Should a backlash arise from government or regulatory bodies, the event’s model could face serious challenges.
For now, the enhanced game presses on with its daring mantra: Live Enhance.
Ultimately, the reception it receives could shape not only the future of this event but the ethical boundaries of sports as a whole.





